Korea · STED Gap Analysis
Pre-Submission STED Technical Dossier Gap Analysis
Audit FDA 510(k) and CE MDR files against MFDS submission mandates to isolate testing, raw material, and V&V gaps before filing.
Domain Expertise
Deep regulatory authority across every medical device domain
SaMD · AI Digital Health
IEC 62304 · Software Lifecycle · MFDS AI/Big Data & DTx Guidance
Identified missing coating composition data; fortified raw material dossier to achieve first-round MFDS approval.
Active Devices · Robotics
IEC 60601-1 / 60601-1-2 (Ed. 4.1) · IEC 60601-2-XX Particular Standards
Essential Performance definition and worst-case test matrix optimization across accredited laboratories
Implants · Biomaterials
ISO 10993-1 to 23 Biocompatibility · ISO 11135 / 11137 Sterilization Validation
Biological endpoint matrix design and ISO 10993-18 chemical characterization / toxicological assessment
In Vitro Diagnostics (IVD)
Korea IVD Act & EU IVDR (2017/746) · CLSI EP Guidelines (EP05, EP06, EP12, EP17)
CLSI-compliant Limit of Detection (LoD), cross-reactivity, interference, and lot-to-lot reproducibility protocols
Proprietary Data & Precedent Validation
Quantitative Auditing Against Historical Deficiency Databases
1:1 Cross-Check Against MFDS Reviewer Checklists & Standards
Engineered 4-Stage Workflow
A 4-Stage Pipeline from Dossier Intake to Remediation Plan
Locked Dossier Inventory & Baseline Freeze
Incomplete baseline data or misclassified regulatory pathways are the primary drivers of multi-month submission delays. Gate 01 locks the device scope, predicate/standard mapping, and full document inventory before authoring begins.
Verification Baseline
Device description, intended use, existing test reports, and QMS document index
Gate Sign-Off Output
Confirmed classification matrix and locked submission master inventory
Agentic Automation & Platform Integration
Automated Dossier Traceability & Remediation Tracking
Automated Claim-to-Evidence Cross-Linking
Maintain live links between technical file claims, ISO 14971 risk controls, and verification reports.
@Document Control— Run "Automated Claim-to-Evidence Cross-Linking" across our STED Gap Analysis records and call out the highest-priority compliance findings first.
I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.
Thought for 4.2s · Explored Document Control records & 14 regulatory clauses
Maintain live links between technical file claims, ISO 14971 risk controls, and verification reports. Full document lifecycle with version control
Structured Gap Remediation Workflows
Assign each identified gap to R&D or RA owners with clear closure criteria and automated status tracking.
@Risk Management— Run "Structured Gap Remediation Workflows" across our STED Gap Analysis records and call out the highest-priority compliance findings first.
I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.
Thought for 4.3s · Explored Risk Management records & 14 regulatory clauses
Keep master global technical files and localized MFDS STED packages synchronized with full audit trails. ISO 14971 risk register linked to design control
Service Specification
Service Scope & Final Deliverables
Scope
We evaluate dossier completeness and scientific evidence against current regulatory expectations (MFDS, FDA, CE MDR).
- Technical documentation (STED) completeness and structural adherence
- General Safety and Performance Requirements (GSPR / Essential Principles) alignment
- Preclinical safety, EMC, biocompatibility, and bench test report currency and scope
- Software lifecycle (IEC 62304), cybersecurity, and usability engineering file audit
- Clinical Evaluation Report (CER) and clinical equivalence rationale validation
Deliverables
Clear, reviewer-ready findings and an actionable remediation roadmap to preempt official deficiency letters.
- Clause-by-clause Technical File / STED Gap Matrix
- Test Report Currency & Supplemental Testing Assessment
- GSPR / Essential Principles Compliance Gap Report
- Clinical Evidence & CER Adequacy Evaluation
- Prioritized Remediation Roadmap & Submission Timeline
| Category | Item / Milestone | Specification & Deliverable |
|---|---|---|
| Scope | Scope 1 | Technical documentation (STED) completeness and structural adherence |
| Scope | Scope 2 | General Safety and Performance Requirements (GSPR / Essential Principles) alignment |
| Scope | Scope 3 | Preclinical safety, EMC, biocompatibility, and bench test report currency and scope |
| Scope | Scope 4 | Software lifecycle (IEC 62304), cybersecurity, and usability engineering file audit |
| Scope | Scope 5 | Clinical Evaluation Report (CER) and clinical equivalence rationale validation |
| Workflow | Stage 1: Dossier Intake & Baseline Audit | Systematic receipt of existing technical documentation, test reports, risk management files, and change records. |
| Workflow | Stage 2: Clause-by-Clause Gap Mapping | Rigorous cross-checking against applicable MFDS notices, FDA guidance documents, and EU MDR regulations. |
| Workflow | Stage 3: Testing & Clinical Evidence Verification | In-depth assessment of laboratory accreditation, testing standard versions, and clinical data sufficiency. |
| Workflow | Stage 4: Remediation Plan & Executive Briefing | Delivery of prioritized deficiency matrix, remediation solutions, timelines, and strategic risk debrief. |
| Deliverables | Deliverable 1 | Clause-by-clause Technical File / STED Gap Matrix |
| Deliverables | Deliverable 2 | Test Report Currency & Supplemental Testing Assessment |
| Deliverables | Deliverable 3 | GSPR / Essential Principles Compliance Gap Report |
| Deliverables | Deliverable 4 | Clinical Evidence & CER Adequacy Evaluation |
| Deliverables | Deliverable 5 | Prioritized Remediation Roadmap & Submission Timeline |
Frequently Asked Questions
Ready to Accelerate Your Korean Regulatory Pathway?
Built on our proprietary MFDS review database, our next-generation regulatory system compresses turnaround times to 1/5 and systematically prevents recurring deficiency cycles.